Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,407 | -63,707 | -30,115 | -78,996 | -54,397 |
| Depreciation Amortization | 3,436 | 2,530 | 1,326 | 5,450 | 4,044 |
| Income taxes - deferred | N/A | N/A | N/A | 345 | N/A |
| Accounts receivable | 4,097 | 4,860 | -4,072 | -84 | 1,868 |
| Accounts payable and accrued liabilities | -8,555 | -3,473 | -1,663 | 3,774 | 195 |
| Other Working Capital | 3,433 | 9,800 | 9,930 | -13,688 | -10,833 |
| Other Operating Activity | 23,748 | 10,344 | 11,323 | 13,203 | 10,148 |
| Operating Cash Flow | $-69,248 | $-39,646 | $-13,271 | $-69,996 | $-48,975 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -688 | -437 | -363 | -750 | -717 |
| Purchase Of Investment | -162,714 | -124,631 | -62,902 | -307,348 | -307,949 |
| Sale Of Investment | 190,068 | 135,514 | 108,766 | 345,089 | 272,974 |
| Investing Cash Flow | $26,666 | $10,446 | $45,501 | $36,991 | $-35,692 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,331 | 14,211 | 10,409 | 3,614 | 2,671 |
| Other Financing Activity | -1,228 | -1,228 | -777 | -534 | -534 |
| Financing Cash Flow | $17,103 | $12,983 | $9,632 | $3,080 | $2,137 |
| Beginning Cash Position | 57,814 | 57,814 | 57,814 | 87,739 | 87,739 |
| End Cash Position | 32,335 | 41,597 | 99,676 | 57,814 | 5,209 |
| Net Cash Flow | $-25,479 | $-16,217 | $41,862 | $-29,925 | $-82,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,248 | -39,646 | -13,271 | -69,996 | -48,975 |
| Capital Expenditure | -688 | -437 | -363 | -750 | -717 |
| Free Cash Flow | -69,936 | -40,083 | -13,634 | -70,746 | -49,692 |